肝素诱导的皮肤病变
Marc Schindewolf1, Edelgard Lindhoff-Last, Ralf J Ludwig
1Division of Vascular Medicine and Haemostaseology, Department of Internal Medicine, Hospital of the Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Lancet (London, England)
|May 31, 2012
概括
肝素诱导的皮肤病变是肝素治疗的常见副作用. 早期识别和不同的治疗对于过敏反应和氨酸诱导的血小板缩至关重要.
科学领域:
- 药理学 药理学 是一个学科.
- 皮肤病学 皮肤病学
- 血液学 血液学 血液学
背景情况:
- 肝素对于预防和治疗血栓塞栓性疾病至关重要.
- 氨酸诱导的皮肤病变是皮下氨酸的常见副作用,可能比已知的更为常见.
- 这些病变可能源于过敏反应或肝素诱导的血小板缺血,这是一个严重的疾病.
研究的目的:
- 为了审查氨酸诱导的皮肤病变的频谱.
- 强调有关流行病学,诊断和差异诊断的证据和争议.
- 讨论这些皮肤病变的患者管理策略.
主要方法:
- 文献综述侧重于肝素诱导的皮肤病变的临床表现,流行病学,诊断和管理.
- 强调区分过敏反应和肝素诱导的血小板缩.
- 确定患者,药物和治疗相关的风险因素.
主要成果:
- 氨酸诱导的皮肤病变以各种方式表现,并与过敏反应和氨酸诱导的血小板缺血有关.
- 鉴于不同的治疗要求,区分这些原因至关重要.
- 已经确定了影响病变发展的危险因素.
结论:
- 肝素诱导的皮肤病变需要迅速识别和适当管理.
- 了解过敏反应和肝素诱导的血小板狭窄症之间的差异诊断对于有效的患者护理至关重要.
- 对风险因素和最佳治疗策略的进一步研究是有必要的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...


